Vietnam Bans & Discloses Key Disinfectants for Washer-Disinfectors

Vietnam’s Ministry of Health and Ministry of Industry and Trade jointly issued a new regulatory measure on May 28, 2026, directly impacting exporters of low-temperature disinfectants used with washer-disinfector medical devices.

New Regulatory Framework Takes Effect

On May 28, 2026, Vietnam published Joint Circular No. 22/2026/TT-BYT, jointly issued by the Ministry of Health and the Ministry of Industry and Trade. The circular places six commonly used low-temperature disinfectants—including glutaraldehyde and ortho-phthalaldehyde (OPA)—on a newly established ‘Prohibited Import + Mandatory Ingredient Disclosure’ list. All importers of disinfectant solutions intended for use with washer-disinfectors must complete full formulation registration and label all active ingredients by September 1, 2026. Products failing to meet this requirement will be denied customs clearance.

Impact Across the Supply Chain

Exporters and Trading Companies

Companies engaged in direct export or trade of washer-disinfector-compatible disinfectants face immediate compliance pressure. The September 1, 2026 deadline requires rapid review of existing product labels, safety data sheets (SDS), and regulatory documentation—especially for formulations containing glutaraldehyde or OPA. Non-compliant shipments risk detention or rejection at Vietnamese ports.

Raw Material Suppliers

Suppliers of active pharmaceutical ingredients (APIs) and biocidal agents must now anticipate increased demand for certified, traceable batches. Buyers may request updated certificates of analysis (CoA), stability data, and proof of non-contamination with banned substances—particularly where multi-source blending occurs.

Formulation Manufacturers

Manufacturers developing or producing ready-to-use disinfectant solutions must reassess their current portfolios. Reformulation may be necessary to replace restricted actives. Technical documentation—including compatibility testing with washer-disinfector hardware and material safety profiles—must be updated to support registration submissions.

Logistics and Regulatory Support Providers

Third-party regulatory consultants, customs brokers, and labeling service providers are seeing rising demand for dossier preparation, Vietnamese-language labeling adaptation, and pre-clearance verification. Timely coordination between technical, legal, and logistics teams is now critical to avoid shipment delays.

Action Items for Affected Businesses

Verify Formulation Against the Prohibited List

Immediately audit all disinfectant products destined for Vietnam against the six banned or disclosure-mandated substances named in Circular No. 22/2026/TT-BYT. Pay special attention to glutaraldehyde and OPA—even if present below threshold concentrations, full disclosure remains mandatory.

Prepare and Submit Registration Dossiers by September 1, 2026

Compile complete technical dossiers including full ingredient lists (with CAS numbers), concentration ranges, manufacturing site details, and Vietnamese-language labels. Submission must occur through Vietnam’s official online portal for chemical and biocide registration managed by the Ministry of Health.

Update Labeling and Safety Documentation

All packaging and accompanying SDS must clearly identify every active ingredient—using standardized IUPAC nomenclature and Vietnamese translations. Labels must also include batch-specific expiry dates, storage conditions, and usage instructions aligned with washer-disinfector OEM specifications.

Assess Supply Chain Traceability and Audit Readiness

Ensure upstream suppliers can provide auditable records supporting ingredient origin, purity, and absence of undeclared co-formulants. Internal quality systems should be prepared for potential post-registration inspections by Vietnamese authorities.

Industry Perspective: A Shift Toward Transparency and Technical Rigor

Analysis shows that Circular No. 22/2026/TT-BYT reflects Vietnam’s broader regulatory evolution—from reactive market access control toward proactive, science-based oversight of medical device ancillaries. Observably, this move signals increasing alignment with ASEAN Common Technical Dossier (CTD) principles and EU Biocidal Products Regulation (BPR) transparency expectations. What deserves closer attention is the compressed 10-week window between publication and enforcement—underscoring the need for manufacturers to embed regulatory intelligence into R&D and commercial planning cycles, not treat compliance as a last-mile activity.

Strategic Implications for Global Market Access

This regulation marks more than a procedural update—it establishes a precedent for mandatory ingredient-level transparency in Vietnam’s medical hygiene sector. For international suppliers, it reinforces that regulatory readiness must now extend beyond device certification (e.g., ISO 15883, EN ISO 14971) to include full chemical stewardship of consumables. While not yet harmonized with global standards, the policy signals Vietnam’s intent to strengthen post-market surveillance and reduce reliance on foreign regulatory acceptances.

Source Information and Verification Notes

This article is based exclusively on the user-provided title, event date (May 28, 2026), and summary describing the issuance of Circular No. 22/2026/TT-BYT by Vietnam’s Ministry of Health and Ministry of Industry and Trade. Specific official source links were not provided in the input and should be verified continuously. Stakeholders are advised to monitor updates from Vietnam’s National Institute of Hygiene and Epidemiology (NIHE), the Chemicals Administration under the Ministry of Industry and Trade, and forthcoming implementation guidelines—particularly regarding dossier submission formats, fee structures, and transitional arrangements for already-cleared stock.